careCycle vs Amgen

Side-by-side comparison of AI visibility scores, market position, and capabilities

Amgen leads in AI visibility (88 vs 40)
careCycle logo

careCycle

EmergingHealthcare

Care Coordination & Transitions

careCycle is a healthcare platform that helps patients navigate post-acute care transitions — discharge planning, home health coordination, and care management after hospital stays. HQ: San Francisco.

AI VisibilityBeta
Overall Score
C40
Category Rank
#365 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
43
Perplexity
38
Gemini
43

About

careCycle is a care transition and post-acute care management platform designed to improve patient outcomes and reduce readmissions following hospital discharge. The company's technology helps care coordinators, discharge planners, and case managers navigate the complex process of transitioning patients from hospital to the next level of care — home health agencies, skilled nursing facilities, rehabilitation centers, or structured home care programs. Post-discharge coordination failures are a major driver of hospital readmissions, which cost the U.S. healthcare system approximately $26 billion annually.

Full profile
Amgen logo

Amgen

LeaderHealthcare Tech

AI Drug Discovery

Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.

AI VisibilityBeta
Overall Score
A88
Category Rank
#3 of 596
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
83
Perplexity
87
Gemini
85

About

Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.

Full profile

AI Visibility Head-to-Head

40
Overall Score
88
#365
Category Rank
#3
83
AI Consensus
78
stable
Trend
stable
43
ChatGPT
83
38
Perplexity
87
43
Gemini
85
45
Claude
90
40
Grok
92

Key Details

Category
Care Coordination & Transitions
AI Drug Discovery
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only careCycle
Care Coordination & Transitions
Only Amgen
AI Drug Discovery

Integrations

Amgen is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.